Literature DB >> 35709248

Interleukin-17 governs hypoxic adaptation of injured epithelium.

Piotr Konieczny1, Yue Xing1, Ikjot Sidhu1,2, Ipsita Subudhi1, Kody P Mansfield1, Brandon Hsieh1, Douglas E Biancur3, Samantha B Larsen4, Michael Cammer5, Dongqing Li6, Ning Xu Landén6, Cynthia Loomis7, Adriana Heguy8, Anastasia N Tikhonova9, Aristotelis Tsirigos1,2, Shruti Naik1,10.   

Abstract

Mammalian cells autonomously activate hypoxia-inducible transcription factors (HIFs) to ensure survival in low-oxygen environments. We report here that injury-induced hypoxia is insufficient to trigger HIF1α in damaged epithelium. Instead, multimodal single-cell and spatial transcriptomics analyses and functional studies reveal that retinoic acid-related orphan receptor γt+ (RORγt+) γδ T cell-derived interleukin-17A (IL-17A) is necessary and sufficient to activate HIF1α. Protein kinase B (AKT) and extracellular signal-regulated kinase 1/2 (ERK1/2) signaling proximal of IL-17 receptor C (IL-17RC) activates mammalian target of rapamycin (mTOR) and consequently HIF1α. The IL-17A-HIF1α axis drives glycolysis in wound front epithelia. Epithelial-specific loss of IL-17RC, HIF1α, or blockade of glycolysis derails repair. Our findings underscore the coupling of inflammatory, metabolic, and migratory programs to expedite epithelial healing and illuminate the immune cell-derived inputs in cellular adaptation to hypoxic stress during repair.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35709248     DOI: 10.1126/science.abg9302

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  2 in total

1.  IL-17 signaling in skin repair: safeguarding metabolic adaptation of wound epithelial cells.

Authors:  Juan Wang; Xiaolei Ding
Journal:  Signal Transduct Target Ther       Date:  2022-10-08

2.  Promoting repair of highly purified stromal vascular fraction gel combined with advanced platelet-rich fibrin extract for irradiated skin and soft tissue injury.

Authors:  Zhou Li; Huimin Gan; Anru Liang; Xiyue Wang; Xiaohao Hu; Ping Liang; Guoding Xu; Qianwen Huang; Junjun Li; Hongmian Li
Journal:  Ann Transl Med       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.